INTRODUCTION
Mycobacterium tuberculosis (MTB) is an intracellular pathogen and is the causative agent of pulmonary tuberculosis which is one of the main causes of morbidity and mortality worldwide (1) . Infection of human macrophages with MTB induces release of a variety of cytokines which participate in protective and immune host responses during human tuberculosis (2) (3) (4) (5) (6) . Downregulation of cytokine receptors in T cells has been reported to result in ineffective control of persisting pathogens such as MTB (7) . MTB induces the expression of a variety of chemokines such as monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), macrophage inflammatory protein-1β (MIP-1β) and regulated upon activation, normal T-cell expressed and secreted (RANTES) (8) (9) (10) (11) (12) . These induced chemokines have been reported to be involved in the inhibition of intracellular MTB growth, formation of granulomas, and the recruitment of lymphocytes and monocytes to pleural cavity in TB patients (13) (14) (15) (16) (17) (18) . Mycobacterial infection induced-expression of a variety of chemokines is known to be mediated via various signaling pathways (19, 20) . However, the signaling pathways by which MTB induces production of a variety of cytokines in macrophages are not yet fully understood. Recent studies have suggested that the mitogen-activated protein kinase (MAPK) pathway is an important component of mycobacterial pathogenesis (21) . The MAPK signaling pathway is a highly conserved pathway that is important in diverse aspects of the immune response (22) (23) (24) . The MAPK family includes ERK, p38 MAPK, and stress-activated protein kinase/c-Jun N-terminal kinase (JNK) (25, 26) . Activation of p38 MAPK has been reported to be induced in monocytes following infection with MTB (27) . In addition, the MAPK signaling pathway was shown to be essential for the mycobacterium-induced production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), IL-1β, and MCP-1 (28, 29) . Recently, it has been demonstrated that leukotactin-1 (Lkn-1), a member of the CC chemokine family, is induced during mycobacterial infection implying the association of Lkn-1 with the development of tuberculosis. In addition, it has been shown that MTB-induced upregulation of Lkn-1 is mediated by the PI3-K/ PDK1/Akt signaling pathway (30, 31) . However, involvement of additional signaling pathways in MTB-induced Lkn-1 regulation is unknown. In the present study, we aimed to elucidate the involvement of the MAPK pathway in MTB-induced expression of Lkn-1. We demonstrated that p38 MAPK and JNK are associated with regulation of Lkn-1 expression in response to MTB infection in macrophages. http://bmbreports.org THP-1 cells were treated with 100 nM PMA for 48 h, and infected with MTB (10 MOI) for 4 h. Total RNA was extracted and cDNA was prepared. PCR analysis was performed using Lkn-1-specific primers and the PCR products were resolved by 1.8% agarose gel (upper panel). GAPDH was used as an internal control. Densitometric analysis was performed (lower panel). Data are expressed as mean ± SD and are presented as expression levels of Lkn-1 mRNA relative to GAPDH mRNA (The expression level of Lkn-1 relative to GAPDH in the absence of mycobacterial infection was set to 1.0). The data represent results from three independent experiments. Statistical analysis was performed by Student's t-test (***P ＜ 0.001 relative to uninfected control). (B) Differentiated THP-1 cells were starved for 16 h and infected with MTB (10 MOI) for the indicated times (0, 15, 30, 60, 120, 180 min) before cell lysates were prepared, Cell lysates were resolved on 12% SDS-polyacrylamide gels and transferred to nitrocellulose membranes. Phosphorylation of JNK, p38 MAPK, ERK, and Akt was detected by Western blotting using anti-phospho-JNK, p38 MAPK, ERK, or Akt, respectively. Beta-actin was used as an internal control.
RESULTS AND DISCUSSION

MTB enhances expression of Lkn-1 and activates MAPKs
Our previous study reported the involvement of Lkn-1 in the immune response of macrophages against MTB and revealed that MTB infection causes increased expression and secretion of Lkn-1 in differentiated THP-1 cells (31) . In the present study, we reconfirmed the infection of THP-1 cells with MTB induced up-regulation of Lkn-1 mRNA (Fig. 1A) . Next, we examined whether infection with MTB activates protein kinases included in the MAPK family which is known to be associated with MTB-induced production of cytokines (22) (23) (24) . THP-1 cells were treated with PMA for 48 h and incubated with MTB for the indicated times. Phosphorylation of MAP kinases was detected by Western blotting. As shown in a previous report (31) , MTB infection activated Akt (Fig. 1B) . In addition, infection of MTB caused phosphorylation of MAP kinases including JNK, p38, and ERK (Fig.  1B) . Data showed that MTB-induced phosphorylation of JNK and p38 MAPK was detectable 30 min after infection and persisted for at least 180 min after MTB infection. This pattern is similar to MTB-induced phosphorylation pattern of Akt. In contrast, phosphorylation of ERK was detectable 15 min after infection but declined thereafter and was undetectable at 120 min after MTB infection (Fig. 1B) . These results suggest that in addition to the previously identified Akt, MAP kinases may be also involved in MTB-induced up-regulation of Lkn-1.
p38 MAPK and JNK are involved in MTB-stimulated up-regulation of Lkn-1
Based on the results above, we determined whether MAP kinases such as JNK, p38, and ERK are associated with MTB-induced expression of Lkn-1. PMA-treated THP-1 cells were pre-treated with the JNK inhibitor (SP600125), the p38 inhibitor (SB202190), or the MEK1 inhibitor (PD98059) for 45 min before exposure to MTB for 4 h. The mRNA level of Lkn-1 was detected by semi-quantitative PCR analysis. As shown in Fig. 2 , treatment with SP600125 (an inhibitor of JNK) or SB202190 (an inhibitor of p38 MAPK) abolished MTB-induction of Lkn-1 in an inhibitor dose-dependent manner. However, pre-treatment with PD98059 (an inhibitor of MEK1) did not influence mRNA induction of Lkn-1 by MTB (Fig. 2) . These data suggests that the p42 and p44 extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathways are not associated with MTB-induced up-regulation of Lkn-1 since MEK1 is an upstream signaling molecule of ERK1/2. These results imply that although JNK, p38, and ERK were all activated in response to MTB infection, only JNK and p38 showed association with MTB-induced Lkn-1 expression. As shown in Fig. 1 , although JNK, p38, and ERK were all activated by infection with MTB, the pattern of activation was different between JNK/p38 MAPK and ERK. Activation of JNK and p38 MAPK persisted for at least 3 h after MTB infection which is similar to the activation pattern of Akt. However, phosphorylation of ERK disappeared at 120 min after MTB infection (Fig. 1B) . It is possible that prolonged activation (for at least more than 3 h) of signaling molecules is required for MTB-induced expression of Lkn-1.
Lkn-1 induction by infection with MTB is mediated through PI3-K to p38/JNK to Akt signaling pathway
We previously demonstrated that the up-regulation of Lkn-1 caused by MTB infection was mediated by PI3-K, PDK1 and Akt (31). Here we determined whether JNK and p38 MAPK activated during MTB-induction of Lkn-1 are separate from or part of the PI3-K/PDK1/Akt signaling pathway. As shown in Fig. 3A , pre-treatment with a JNK inhibitor (SP600125) or p38 inhibitor (SB202190) before infection with MTB diminished MTB-induced http://bmbreports.org BMB Reports Subsequently, cells were infected with MTB (10 MOI) for the indicated times before cell lysates were prepared, resolved on 12% SDS-polyacrylamide gels and transferred to nitrocellulose membranes. Akt phosphorylation was determined by Western blotting using anti-phopho-Akt antibody. Differentiated THP-1 cells were starved for 16 h, and treated with Ly294002 (20 μM) or OSU03012 (5 μM) for 45 min. Subsequently, cells were infected with MTB (10 MOI) for the indicated times before cell lysates were prepared. Phosphorylation of p38 MAPK (B) or JNK (C) was determined by Western blotting using anti-phopho-p38 MAPK and anti-phopho-JNK antibody, respectively. Beta-actin was used as an internal control.
phosphorylation of Akt. The levels of phosphorylated p38 MAPK and JNK were not affected by pre-treatment with the Akt inhibitor before stimulation with MTB (data not shown). These results show that JNK and p38 are upstream molecules of Akt in the signaling pathway.
In addition, differentiated THP-1 cells were pre-treated with Ly294002 (PI3-K inhibitor) or OSU03012 (PDK1 inhibitor) before exposure to MTB and phosphorylation of JNK and p38 http://bmbreports.org MAPK was assessed. Ly294002 treatment partially prevented phosphorylation of JNK and p38 MAPK (Fig. 3B and C, middle  panel) . In contrast, inhibition of PDK1 did not influence the levels of phosphorylated JNK and p38 MAPK (Fig. 3B and C, right  panel) . These data suggest that PI3-K is an upstream kinase of p38 MAPK and JNK in the signal pathway associated with up-regulation of Lkn-1 by MTB infection. In contrast, PDK1 does not seem to be an upstream molecule of p38 MAPK or JNK in this signal pathway. These results imply that increased expression of Lkn-1 in response to MTB infection is mediated via three pathways: the PI3-K/PDK1/Akt, PI3-K/p38 MAPK/Akt, and the PI3-K/JNK/Akt signaling pathways (Fig. 4) . Further studies are needed to determine if JNK and p38 MAPK are upstream molecules of PDK1.
In conclusion, in addition to the previously reported PI3-K/ PDK1/Akt pathway, we identified two additional signaling molecules, p38 MAPK and JNK, involved in MTB-induced Lkn-1 expression in PMA-differentiated THP-1 cells. The elucidation of the signaling pathways involved in MTB-induced Lkn-1 expression during tuberculosis development may provide useful information which can be exploited for therapeutic intervention.
MATERIALS AND METHODS
Materials
Specific inhibitors of p38 MAPK (SB202190), MEK1 (PD98059), JNK (SP600125), PI3-K (Ly294002) were purchased from Calbiochem (San Diego, CA, USA). Specific inhibitors of PDK1 (OSU-03012) were purchased from Cayman (Ann Arbor, MI, USA). Dimetyl sulphoxide (DMSO) was obtained from Sigma-Aldrich (St. Louis, MO, USA).
Preparation of mycobacteria
MTB H37Rv (ATCC 27294) used in this study was grown for about four weeks at 37°C as a surface pellicle on Sauton medium enriched with 0.4% sodium glutamate and 3.0% glycerol. The surface pellicles were collected and disrupted by gentle vortexing with 6 mm glass beads. After clumps were settled, the upper suspension was collected and aliquots were stored at −80 o C. Before infection, aliquots were thawed and quantitated for viable colony-forming units (CFU) on Middlebrook 7H10 agar (Difco, Detroit, MI, USA).
Cell culture and infection of MTB
The THP-1 cells were maintained in RPMI 1640 medium with 2 mM glutamine, 10% heat inactivated fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco-BRL, Grand Island, NY, USA) at 37 o C under 5% CO2. THP-1 cells were seeded in six-well plates and treated with 100 nM phorbol-12-myristate-13-acetate (PMA; Sigma) for 48 h to induce differentiation into macrophage-like cells, then washed three times with RPMI 1640 medium. Before infection, differentiated THP-1 cells were reconstituted in antibiotic free RPMI 1640 medium with 10% FBS. PMA-differentiated THP-1 cells were pretreated with inhibitors for 45 min before stimulation with MTB H37Rv for 4 h at MOI 10.
RNA extraction and semi-quantitative reverse transcriptase PCR (RT-PCR)
After removing nonphagocytosed bacilli, total RNA was extracted from cultured cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. cDNA was synthesized by reverse transcription with 2 μg total RNA, 0. o C for 30s) using the Lkn-1 primer (sense 5´-CCTCTCCTG CCTCATGCTTA-3´, antisense 5´-ACTGGGTTTGGCACAGACTT-3´). GAPDH was amplified as an internal control with primers (sense 5´-CGGGAAGCTTGTGATCAATGG-3´, antisense 5´-GG CAGTGATGGCATGGACTG-3´). PCR products were electrophoresed on 1.8% (w/v) agarose gels containing 0.5 μg/ml ethidium bromide, and the sizes of the products were determined by comparison to the 100 bp DNA ladder marker (Bioneer, Daejeon, Korea). The intensity of each band amplified by RT-PCR was analyzed using Gel Doc EQ Quantity One (version 4.5, Bio-Rad, Milan, Italy) and normalized to GAPDH mRNA in corresponding 587 http://bmbreports.org BMB Reports samples.
Western blot analysis
PMA-differentiated THP-1 cells were grown in six-well plates and were starved for 16 h, pretreated with inhibitors for 45 min, then infected with MTB for 0, 15, 30, 60, 120 or 180 min. After incubation, cells were washed twice in ice-cold phosphate-buffered saline (PBS) and solubilzed in lysis buffer containing 10 mM Tris (pH 7.0), 140 mM NaCl containing proteinase inhibitors (Roche, Basel, Switzerland) and phophatase inhibitor(s) (Thermo scientific, Waltham, MA, USA). Samples of equal amounts of protein (40 ug) were subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to a nitrocellulose membrane. The membrane was blocked in Tris-buffered saline with 0.1% Tween-20 (TBST) buffer containing 5% non-fat milk. Also, immunoblotting was performed with anti-phospho-Akt (Ser473), p38 MAPK (Thr180/ Tyr182), JNK (Thr183/Tyr185), or ERK (Thr202/Tyr204) (Cell Signaling Technology, Danvers, MA, USA) (32) . Immunoreactive proteins were detected by horseradish peroxidase-conjugated secondary antibody (Jackson Immunoresearch Laboratories, West Grove, PA, USA). The blot was developed with a chemiluminescent system (Pierce, Rockford, IL, USA).
Statistics
All values are given as mean ± standard deviation (SD). When a significant difference was detected, further analysis was performed using a Student's t-test. A P value of less than 0.05 was considered significant (GraphPad Prism 4 Software, SanDiego, CA, USA)
